← Back to Search

Other

ALTO-100 PO Tablet for Depression

Phase 2
Waitlist Available
Research Sponsored by Alto Neuroscience
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at day 1, day 14, day 28, day 42, day 56
Awards & highlights

Summary

This trial is studying a new treatment called ALTO-100. It includes a wide range of participants and aims to understand how the treatment affects the body by collecting biological data.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at day 1, day 14, day 28, day 42, day 56
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at day 1, day 14, day 28, day 42, day 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Clinically Significant Laboratory Abnormalities as a Measure of Safety and Tolerability of ALTO-100
Number of Participants with Adverse Events (AEs) as a Measure of Safety and Tolerability of ALTO-100
To understand the relationship between baseline biology and score change in the Clinical Global Impression scale - Severity (CGI-S) with ALTO-100 from Screening to end of treatment
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ALTO-100Experimental Treatment1 Intervention
ALTO-100 tablet PO ; twice daily dosing 8 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ALTO-100 PO Tablet
2022
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

Alto NeuroscienceLead Sponsor
8 Previous Clinical Trials
1,010 Total Patients Enrolled
8 Trials studying Depression
1,010 Patients Enrolled for Depression
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top